ABSTRACT
BACKGROUND AND AIMS: Biliary atresia (BA) is a cholestatic, fibro-obliterative cholangiopathy of unknown etiology. BA is primarily treated by a surgical approach, that is, the Kasai portoenterostomy (KPE), to obtain clearance of jaundice (COJ). The gut microbiota (GM) composition has been associated with the course of several cholestatic liver diseases. It is largely unknown, however, whether GM composition associates with the outcome of KPE. We compared the GM composition of BA patients and controls and assessed if GM composition before KPE was related to COJ after KPE. METHODS: We compared feces of term-born BA patients before KPE and controls (patients undergoing inguinal hernia repair) by 16S rRNA sequencing. Composition and alpha diversity of the GM were compared between BA and controls before KPE and after KPE, between patients with COJ versus without COJ (total serum bilirubin < or ≥20âµmol/L <6 months post-KPE). RESULTS: Alpha diversity was comparable between BA (nâ=â12, age 1.6 [1.3-1.8] months) and controls (nâ=â6, age 2.0 [1.4-2.1] months; Pâ=â0.22). Compared with controls, BA patients had lower abundances of Bifidobacteriaceae (ßâ=â-1.98, Pâ<â0.001) and Lachnospiraceae (ßâ=â-1.84, Pâ=â0.007), and higher abundances of Streptococcus (ßâ=â-1.13, Pâ=â0.003). The alpha diversity before KPE correlated negatively with COJ (Râ=â-0.63, Pâ=â0.03). Lower alpha diversity pre-KPE was associated with COJ [+] (ßlogitâ=â-0.64, Pâ=â0.04). We observed greater abundances of genus Acinetobacter (ßâ=â1.27, Pâ=â0.03) and family Clostridiaceae (ßâ=â1.45, Pâ=â0.03) and lower abundances of the family Enterobacteriaceae (genera Klebsiella (ßâ=â-1.21, Pâ=â0.01), Salmonella (ßâ=â-1.57, Pâ=â0.02)) in COJ [+] versus COJ [-]. CONCLUSIONS: The GM of BA patients before Kasai portoenterostomy associates with outcome, clearance of jaundice, suggestive of predictive, and mechanistic roles of the gut microbiota composition in bile homeostasis.
Subject(s)
Biliary Atresia , Gastrointestinal Microbiome , Jaundice , Biliary Atresia/surgery , Child, Preschool , Humans , Infant , Portoenterostomy, Hepatic , RNA, Ribosomal, 16S/geneticsABSTRACT
OBJECTIVES: Environmental factors may be involved in the pathogenesis of biliary atresia (BA). This epidemiological study aimed to analyze the relationships between the incidence of BA, the incidence of confirmed viral or bacterial infections and population density, and geographical and temporal clustering of BA in the Netherlands. STUDY DESIGN: Correlations between the monthly incidence of BA and the number of confirmed infections were assessed. BA incidence per province was calculated and compared to the province with highest population density. Birthplaces were classified as rural or urban. Temporal clustering of month of birth and month of conception were analyzed. We performed analyses for isolated BA (IBA) and syndromic BA (SBA) separately. Chi2, logistic regression, and Walter and Elwood test were used. RESULTS: A total of 262 IBA and 49 SBA patients, born between 1987 and 2018, were included. IBA incidence correlated to the number of confirmed infections of, for example, Chlamydia trachomatis (Râ=â0.14; Pâ=â0.02) and adenovirus (Râ=â0.22; Pâ=â0.005). We observed a higher incidence of IBA (0.75/10,000; odds ratio [OR]â=â1.86; Pâ=â0.04) and SBA (0.27/10,000; ORâ=â6.91; Pâ=â0.001) in Groningen and a higher incidence of SBA in Gelderland (0.13/10,000; ORâ=â3.35; Pâ=â0.03). IBA incidence was 68% higher in rural (0.67/10,000) versus urban areas (0.40/10,000) (Pâ=â0.02). The estimated month of conception of patients with SBA clustered in November (85% increase compared to average SBA incidence [0.09/10,000; Pâ=â0.04]). CONCLUSIONS: IBA incidence correlated weakly with national confirmed infections. IBA and SBA incidence varied geographically in the Netherlands. IBA incidence was higher in rural than in urban areas, which may be explained decreased exposure to pathogens. Our results provide support for a role of environmental factors in the pathogenesis of IBA.
Subject(s)
Biliary Atresia , Biliary Atresia/epidemiology , Biliary Atresia/etiology , Epidemiologic Studies , Humans , Incidence , Netherlands/epidemiology , Rural PopulationSubject(s)
Bile , Liver , Humans , ATP Binding Cassette Transporter, Subfamily B, Member 11 , Bile Acids and SaltsSubject(s)
Biliary Atresia , COVID-19 , Biliary Atresia/complications , Biliary Atresia/surgery , Communicable Disease Control , Humans , Infant , SARS-CoV-2ABSTRACT
BACKGROUND: Biliary atresia (BA) is a rare cholangiopathy where one of the proposed aetiological mechanisms is an infectious viral trigger. Coronavirus disease-19 (COVID) lockdown restrictions were implemented to reduce the transmission of infections. Strictness of lockdown varied across European countries. This study aimed to investigate if there was an association between strictness of lockdown and change in isolated BA (IBA) incidence in Europe. METHODS: We approached European centres involved in the European Reference Network RARE-LIVER. We included IBA patients born between 2015 and June 2020. We calculated the number of IBA patients born per centre per month. The Stringency Index (SI) was used as lockdown strictness indicator. The association between percentage change of mean number of IBA patients born per month and the SI was assessed. RESULTS: We included 412 IBA patients from thirteen different centres. The median number of patients per month did not change: 6 (1-15) pre-lockdown and 7 (6-9) during lockdown (p = 0.34). There was an inverse association between SI and percentage change in IBA (B = -0.73, p = 0.03). Median age at Kasai portoenterostomy (days) did not differ between time periods (51 (9-179) vs. 53 (19-126), p = 0.73). CONCLUSION: In this European study, a stricter COVID-lockdown was seemingly accompanied by a simultaneous larger decrease in the number of IBA patients born per month in the lockdown. Results should be interpreted with caution due to the assumptions and limitations of the analysis.
ABSTRACT
Biliary atresia (BA) is a rare cholangiopathy of infancy in which the bile ducts obliterate, leading to profound cholestasis and liver fibrosis. BA is hypothesized to be caused by a viral insult that leads to over-activation of the immune system. Patients with BA are surgically treated with a Kasai portoenterostomy (KPE), which aims to restore bile flow from the liver to the intestines. After KPE, progressive liver fibrosis is often observed in BA patients, even despite surgical success and clearance of their jaundice. The innate immune response is involved during the initial damage to the cholangiocytes and further differentiation of the adaptive immune response into a T-helper 1 cell (Th1) response. Multiple studies have shown that there is continuing elevation of involved cytokines that can lead to the progressive liver fibrosis. However, the mechanism by which the progressive injury occurs is not fully elucidated. Recently, matrix metalloproteinase-7 (MMP-7) has been investigated to be used as a biomarker to diagnose BA. MMPs are involved in extracellular matrix (ECM) turnover, but also have non-ECM related functions. The role of MMP-7 and other MMPs in liver fibrosis is just starting to be elucidated. Multiple studies have shown that serum MMP-7 measurements are able to accurately diagnose BA in a cohort of cholestatic patients while hepatic MMP-7 expression correlated with BA-related liver fibrosis. While the mechanism by which MMP-7 can be involved in the pathophysiology of BA is unclear, MMP-7 has been investigated in other fibrotic pathologies such as renal and idiopathic pulmonary fibrosis. MMP-7 is involved in Wnt/ß-catenin signaling, reducing cell-to-cell contact by shedding of E-cadherin, amplifying inflammation and fibrosis via osteopontin (OPN) and TNF-α while it also appears to play a role in induction of angiogenesis This review aims to describe the current understandings of the pathophysiology of BA. Subsequently, we describe how MMP-7 is involved in other pathologies, such as renal and pulmonary fibrosis. Then, we propose how MMP-7 can potentially be involved in BA. By doing this, we aim to describe the putative role of MMP-7 as a prognostic biomarker in BA and to provide possible new therapeutic and research targets that can be investigated in the future.